Angel Yeast strengthens its core competitiveness; in 2025, net profit after deducting non-recurring gains and losses was 1.36 billion, up 16%.

Yangtze Business Daily report ●Yangtze Business Daily reporter Xu Liangli

Angqi Yeast (600298.SH) delivered encouraging results in 2025. The company has recently released its 2025 annual report, showing that in 2025 the company achieved operating revenue of RMB 16.73B, up 10.08% year over year; attributable net profit to shareholders of RMB 1.54B, up 16.60% year over year; and non-recurring items attributable net profit of RMB 1.36B, up 16.19% year over year.

Angqi Yeast is a national key high-tech enterprise specializing in the operation of yeast, yeast derivatives, and related biological products; it is also a listed company and the world’s second-largest yeast company.

In its annual report, Angqi Yeast mentioned that in 2025 the company’s full-year yeast production reached 456k tons, up 40k tons year over year. Production capacity at newly built projects—such as those in the Yichang High-tech Zone, Kashgar, Chifeng, and others—was fully released. The company successfully achieved yeast-protein production through multiple factories and multiple processes, effectively ensuring the rapidly growing market demand. Completion rates for orders of its leading products were all above 99.5%.

In product innovation, in 2025 Angqi Yeast launched multiple new products, including a milk series for baking, low-sugar high-activity dried yeast, Fubang non-active yeast, Angqi Nut children’s growth formula milk powder, yeast powder, and more, forming a yeast protein product system with full coverage of protein ratios. The development results of nitrogen-source replacement for agricultural and sideline products into dedicated products and application solutions were significant, creating a new growth point for the microbial nutrition business. Products such as low-cost low-sugar yeast, yeast extract, cake oil, and others completed strain iteration and process improvements, with a successful and notable cost reduction and efficiency improvement.

In major project construction, in 2025 Angqi Yeast carried out the acquisition of Shengtong Sugar Industry’s equity. Multiple projects were completed and went into production, including the yeast protein project of the High-tech Zone company and the microgranule fertilizer production line project of the Binzhou company. The headquarters biomanufacturing intelligent center and the new factory in Indonesia are being accelerated in construction.

Angqi Yeast’s 2025 annual report shows that in 2025 the company achieved operating revenue of RMB 456k, up 10.08% year over year; attributable net profit to shareholders of RMB 40k, up 16.60% year over year; non-recurring items attributable net profit of RMB 16.73B, up 16.19% year over year; basic earnings per share of RMB 1.78, up 14.84% year over year; and net cash flow from operating activities of RMB 1.54B, up 50.19% year over year. The company plans to use the company’s total share capital of 867,848,671 shares as of the end of 2025 as the base to distribute cash dividends of RMB 5.5 per 10 shares (including tax). The total expected distribution amount is RMB 477 million.

Angqi Yeast “goes global” relatively early. In recent years, international development has been pushed deeper. As of now, Angqi Yeast has successfully set up subsidiaries in Turkey and Indonesia, started preparations for a Belgium biotechnology innovation and R&D center, completed the expansion and upgrade of factories in Russia and Egypt, and laid out and is building an Algeria packaging and filling factory. The Indonesian plant has officially started construction. Supported by its strong global layout, Angqi Yeast’s international market business has performed impressively, maintaining a relatively high growth rate. It achieved operating revenue of RMB 1.36B, up 19.88% year over year.

Angqi Yeast has built a “three-in-one” R&D system: “microbial strain resource mining—fermentation extraction process research—product and application solution development.” By systematically integrating key steps such as strain screening, gene editing, fermentation regulation, product development, and application, it has connected the complete innovation chain from basic research to industrialized applications. It has achieved full-process technological coverage from microbial strain resources to terminal solution development. The company provides customized technical services and innovative products for multiple fields including food, biopharmaceuticals, and bio-agriculture, continuously strengthening its core competitiveness in the biomanufacturing and fermentation domain.

According to its plan, in 2026 Angqi Yeast will continue to make efforts in areas such as technological innovation and user experience, consolidate its leading position in the global market, expand into new tracks around areas of big health foods, biopharmaceuticals, and bio-agriculture, and build new business growth points.

Editor in charge: ZB

Massive information and precise analysis—on Sina Finance APP